This Biotech Stock Is Ready for Another Leg Up
If you’re into biotech stock opportunities, you know the sector has been suppressed lately: XBI, a broad-based biotech ETF That’s due to some macro factors – including the ability to find patients and the costs of the trials. Now that interest rates are starting to ease, it may attract more institutional investment into the space……